Biogen, Inc. (BIIB)
177.47
+1.63
(+0.93%)
USD |
NASDAQ |
Dec 10, 16:00
177.50
+0.03
(+0.02%)
After-Hours: 17:02
Biogen Free Cash Flow: 2.262B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Eli Lilly & Co. | 6.436B |
| Merck & Co., Inc. | 13.05B |
| Pfizer Inc. | 10.38B |
| Stoke Therapeutics, Inc. | 52.37M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.272B |
| Cash from Investing (Quarterly) | -35.10M |
| Cash from Financing (Quarterly) | -130.20M |
| Free Cash Flow Per Share (Quarterly) | 8.300 |
| Free Cash Flow to Equity (Quarterly) | 1.226B |
| Free Cash Flow to Firm (Quarterly) | 1.277B |
| Free Cash Flow Yield | 8.69% |